T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Campbell Soup
CPB
$6.92B
| $7.82M | ﹤0.01% |
280,462
-5
| -0% | -$150 |
|
1277
Flowserve
FLS
$10.4B
| $7.79M | ﹤0.01% |
112,223
+3,349
| +3% | +$215K |
|
1278
Blue Bird Corp
BLBD
$2.09B
| $7.77M | ﹤0.01% |
165,249
+17,865
| +12% | +$934K |
|
|
OKLO
1279
Oklo
OKLO
$8.66B
| $7.74M | ﹤0.01% |
107,866
-177,414
| -62% | -$19.8M |
|
|
CLYM
1280
Climb Bio
CLYM
$876M
| $7.7M | ﹤0.01% |
1,923,639
+1,396,722
| +265% | +$3.35M |
|
1281
OFG Bancorp
OFG
$2.26B
| $7.68M | ﹤0.01% |
187,428
+18,460
| +11% | +$756K |
|
|
MICC
1282
The Magnum Ice Cream Company N.V.
MICC
$12B
| $7.67M | ﹤0.01% |
+483,615
| New | +$7.58M |
|
1283
OGE Energy
OGE
$9.74B
| $7.66M | ﹤0.01% |
179,369
+3,891
| +2% | +$174K |
|
1284
SouthState Bank Corp
SSB
$10.8B
| $7.59M | ﹤0.01% |
80,664
+4,233
| +6% | +$392K |
|
1285
Absci
ABSI
$1.55B
| $7.53M | ﹤0.01% |
2,156,067
+2,085,501
| +2,955% | +$7.6M |
|
1286
Full Truck Alliance
YMM
$9.17B
| $7.49M | ﹤0.01% |
697,661
| – | – |
|
1287
Fomento Económico Mexicano
FMX
$39.9B
| $7.47M | ﹤0.01% |
73,946
-4,200
| -5% | -$408K |
|
1288
Commercial Metals
CMC
$8.03B
| $7.45M | ﹤0.01% |
107,555
+2,170
| +2% | +$136K |
|
|
CADE
1289
DELISTED
Cadence Bank
CADE
| $7.42M | ﹤0.01% |
173,189
+5,546
| +3% | +$220K |
|
1290
Alvotech
ALVO
$1.37B
| $7.36M | ﹤0.01% |
1,434,153
-19,557
| -1% | -$124K |
|
1291
Hawkins
HWKN
$2.73B
| $7.29M | ﹤0.01% |
51,310
-8,792
| -15% | -$1.29M |
|
|
FYBR
1292
DELISTED
Frontier Communications
FYBR
| $7.22M | ﹤0.01% |
189,778
+14,967
| +9% | +$566K |
|
1293
CareTrust REIT
CTRE
$9.17B
| $7.19M | ﹤0.01% |
198,770
+20,084
| +11% | +$720K |
|
1294
Vontier
VNT
$4.46B
| $7.18M | ﹤0.01% |
193,078
-865,748
| -82% | -$33.1M |
|
1295
Zions Bancorporation
ZION
$10.6B
| $7.13M | ﹤0.01% |
121,756
+5,237
| +4% | +$285K |
|
1296
Wintrust Financial
WTFC
$11B
| $7.12M | ﹤0.01% |
50,928
+2,656
| +6% | +$353K |
|
1297
Shattuck Labs
STTK
$724M
| $7.03M | ﹤0.01% |
+1,926,140
| New | +$4.6M |
|
1298
Lithia Motors
LAD
$8.31B
| $6.92M | ﹤0.01% |
20,820
+192
| +0.9% | +$61K |
|
1299
Old National Bancorp
ONB
$10.4B
| $6.89M | ﹤0.01% |
308,974
+10,462
| +4% | +$226K |
|
1300
Cleveland-Cliffs
CLF
$6.9B
| $6.87M | ﹤0.01% |
517,310
+116,502
| +29% | +$1.47M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.